Journal Browser

Go Edit a Special Issue

Archive

Special Issue Title:

Cardiopulmonary emergencies in the COVID-19 era: What is on the horizon?

Deadline for manuscript submissions: 19 March 2022

Print Special Issue Flyer (19)

Special Issue Editor

  • Guest Editor

    Prof. Ozgur KARCIOGLU, MD, FEMATE-MailWebsite

    Dept. of Emergency Medicine, Univ. of Health Sciences, Istanbul Education and Research Hospital, Fatih, Istanbul, Turkey

    Interests: Resuscitation, Pain management, Disaster medicine, Trauma and toxicology

Special Issue Information

The pandemic infection COVID-19 has changed the world considerably in almost every aspect: Economics, social issues, health care, politics, etc. Substantial changes had their negative impact on healthcare systems around the world. Most importantly, health care organization has evolved to screen and diagnose suspected patients with COVID-19, and to commence their treatment expediently and economically. This challenge, per se, represented a shift of resource allocation to specific diseases such as cardiopulmonary diseases.


As a result, patients have experienced remarkable difficulties to be seen and followed up by their regular physicians, to find beds in the hospitals to be admitted to, even in ICU beds in extremis.


Cardiopulmonary diseases including COPD, pulmonary embolism and thromboembolism, asthma, bacterial and fungal pneumoniae, acute coronary syndromes, cardiomyopathies and heart failure, arrhythmias, and cerebrovascular diseases lack the attention they usually attracted in the past.


This special issue aims to cover topics related to the challenge launched by the pandemic disease on the cardiopulmonary emergencies in general, while addressing the most specific areas like coronary syndromes, arrhythmias, and acute and chronic pulmonary diseases etc.


Keywords

COVID-19, Cardiopulmonary diseases, emergency medicine, intensive care, healthcare system, diagnosis, treatment

Manuscript Submission Information

Manuscripts should be submitted online by submit system. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Original articles, case reports or comprehensive reviews are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Signa Viate is an international peer-reviewed open access journal published by MRE Press. As of January 2021, Signa Vitae will change to a bimonthly journal. Please visit the Instructions for Authors page before submitting a manuscript.The Article Processing Charge (APC) for publication in this open access journal is $1200. We normally offer a discount greater than 30% to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.

Share This Special Issue

Plan Papers (0 papers)

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 0.5(2019) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time

Conferences